Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1747.8000 -11.00 (-0.63%)
NSE Jul 31, 2026 15:31 PM
Volume: 138.0K
 

logo
Ipca Laboratories Ltd.
02 Jun 2026, 12:00AM
1747.80
-0.63%
Emkay
Ipca’s 4QFY26 EBITDA was ahead of our expectations (broadly in line with the consensus’). The beat was driven by higher overall sales, a marginally higher gross margin, as well as lower staff costs.
Number of FII/FPI investors increased from 246 to 256 in Jun 2026 qtr.
More from Ipca Laboratories Ltd.
Recommended